Tucson-based University of Arizona researchers have identified a biomarker that appears in patients before they develop stomach cancer.
In Wisconsin, Epic and Exact Sciences are decreasing COVID-19 test turnaround time by inputting results directly into Epic’s MyChart program.
CMS issued a proposal that declined to cover the first FDA-approved blood-based colorectal cancer screening test, but created a guideline for still-in-development tests to earn approval.
Gastroenterology-focused Dr. Reddy’s Laboratories was the victim of a cyberattack.
Using a noninvasive test to screen for colorectal cancer when a patient turned 45 years old added life years and decreased CRC incidence compared to starting screening when a patient turned 50 years old.
COVID-19 patients with gastrointestinal symptoms had higher admission rates to hospitals and intensive care units and higher intubation rates than those without GI symptoms, according to a poster presented at ACG 2020, Oct. 23-28.
More articles on surgery centers:
5 employees of U of New Mexico outpatient surgery center test positive for COVID-19
ASC leaders on top priorities during COVID-19 pandemic
ASCs projected to take 68% of orthopedic surgeries by mid-decade — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
